1. Aarden, E., Blasimme, A., Holloway, D., & Marelli, L. (2015‚ May 18–19). Making sense of clinical translation: Ethical, regulatory and policy challenges for the EU and the US. Position paper presented at the international workshop Making Sense of Clinical Translation. Hermance: Brocher Foundation.
2. Aguilar, A., Bochereau, L., & Matthiessen, L. (2009). Biotechnology as the engine for the knowledge-based bio-economy. Biotechnology and Genetic Engineering Reviews, 26(1), 371–388.
3. Aguilar, A., Magnien, E., & Thomas, D. (2013). Thirty years of European biotechnology programmes: From biomolecular engineering to the bioeconomy. New Biotechnology, 30(5), 410–425.
4. Anderson, B. (1991). Imagined communities. London: Verso.
5. Badii, R. (2008). EU red biotechnology regulation and European values. In The search for a European identity: Values, policies and legitimacy of the European Union. Abingdon: Routledge